Iovance Biotherapeutics
Price & Volume
Stats
See more52W Range | $3.33-$14.77 |
Market Cap | $1.1B |
Shares Short | 63M |
Financials
See moreRevenue (12 Mos) | $164M |
Revenue Growth (YoY) | 15,189.2% |
Gross Profit (12 Mos) | $40M |
Diluted EPS | -$1.28 |
News
See moreYahoo Finance • 6 days ago
1 Stock Worth Buying Near Its 52-Week Low, According to Wall Street
Yahoo Finance • 6 days ago
3 Growth Stocks Wall Street Might Be Sleeping On -- But I'm Not
Yahoo Finance • 7 days ago
Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)
Yahoo Finance • 29 days ago
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Fourth Quarter and Full Year 2024
About
CEO | Dr. Frederick G. Vogt Esq., J.D., Ph.D. |
CFO | Mr. Jean-Marc Bellemin M.B.A. |
Address | 825 Industrial Road, San Carlos, CA, United States, 94070 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 838 |
